← Leaderboards
Pei-Yi Lin
Massachusetts General Hospital
$3,352,326
Attributed
$6,638,618
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,638,618 · 4
By mechanism
R01$5,624,940 · 2
R00$739,678 · 1
K99$274,000 · 1
Top collaborators
- Benjamin Curtis Warf5 shared
- Patricia Ellen Grant4 shared
- Janet Susan Soul4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Giorgio Bonmassar$14,077,156
- Joseph C. Glykys$3,087,118
- Ralph Weissleder$110,468,710
- Paola Arlotta$53,648,586
- Clarissa Zimmerman Cooley$2,879,122
Others in their field
Top investigators on “Devices”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$199,696,645
- David Heimbrook · Leidos Biomedical Research, Inc.$141,696,528
- Daniel Ernest Ford · Johns Hopkins University$129,841,670
- Richard A Gibbs · Baylor College Of Medicine$118,056,644
Research focus
DevicesCerebrovascular CirculationOxygenSpectrum AnalysisTechnologyDiffuseLeadMetabolismSeveritiesInfantMonitorNeonatalMeasurementFundingCerebrumBrainHydrocephalusBaseNeurodevelopmentGrowthOpticsBrain InjuriesFrequenciesBoston
Grant awards (14)
Neonatal Hypoxic Ischemic Encephalopathy: Potential of Innovative NIRS to Optimize Hypothermia$758,755
R01 · FY2025 · HD
Neonatal Hypoxic Ischemic Encephalopathy: Potential of Innovative NIRS to Optimize Hypothermia$751,613
R01 · FY2024 · HD
Neonatal Hypoxic Ischemic Encephalopathy: Potential of Innovative NIRS to Optimize Hypothermia$731,187
R01 · FY2023 · HD
Neonatal Hypoxic Ischemic Encephalopathy: Potential of Innovative NIRS to Optimize Hypothermia$601,377
R01 · FY2022 · HD
Improving infant hydrocephalus outcomes in Uganda: Predicting developmental outcomes and identifying patients at risk for early treatment failure after ETV/CPC$515,374
R01 · FY2022 · HD · contact PI
Improving infant hydrocephalus outcomes in Uganda: Predicting developmental outcomes and identifying patients at risk for early treatment failure after ETV/CPC$536,941
R01 · FY2021 · HD · contact PI
Improving infant hydrocephalus outcomes in Uganda: Predicting developmental outcomes and identifying patients at risk for early treatment failure after ETV/CPC$560,796
R01 · FY2020 · HD · contact PI
Improving infant hydrocephalus outcomes in Uganda: Predicting developmental outcomes and identifying patients at risk for early treatment failure after ETV/CPC$573,903
R01 · FY2019 · HD · contact PI
Beside Monitor of Cerebral Metabolism in Premature Infants with Intraventricular$248,893
R00 · FY2019 · HD · contact PI
Improving infant hydrocephalus outcomes in Uganda: Predicting developmental outcomes and identifying patients at risk for early treatment failure after ETV/CPC$594,994
R01 · FY2018 · HD · contact PI
Beside Monitor of Cerebral Metabolism in Premature Infants with Intraventricular$241,941
R00 · FY2018 · HD · contact PI
Beside Monitor of Cerebral Metabolism in Premature Infants with Intraventricular$248,844
R00 · FY2017 · HD · contact PI
Beside Monitor of Cerebral Metabolism in Premature Infants with Intraventricular Hemorrhage and Post-Hemorrhagic Hydrocephalus$137,000
K99 · FY2016 · HD · contact PI
Beside Monitor of Cerebral Metabolism in Premature Infants with Intraventricular Hemorrhage and Post-Hemorrhagic Hydrocephalus$137,000
K99 · FY2015 · HD · contact PI